BRPI1002298A8 - pharmaceutical composition for dairy animals - Google Patents

pharmaceutical composition for dairy animals

Info

Publication number
BRPI1002298A8
BRPI1002298A8 BRPI1002298A BRPI1002298A BRPI1002298A8 BR PI1002298 A8 BRPI1002298 A8 BR PI1002298A8 BR PI1002298 A BRPI1002298 A BR PI1002298A BR PI1002298 A BRPI1002298 A BR PI1002298A BR PI1002298 A8 BRPI1002298 A8 BR PI1002298A8
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
dairy animals
animals
relates
glucans
Prior art date
Application number
BRPI1002298A
Other languages
Portuguese (pt)
Inventor
Edson De Souza Moura
Elbi Bernardes De Queiroz Júnior
Juliana Johansson Soares
Márcio Liboni
Original Assignee
Vallée S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vallée S A filed Critical Vallée S A
Publication of BRPI1002298A2 publication Critical patent/BRPI1002298A2/en
Publication of BRPI1002298A8 publication Critical patent/BRPI1002298A8/en
Publication of BRPI1002298B1 publication Critical patent/BRPI1002298B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

composiçâo farmaceutica para animais produtores de leite. a presente invenção se refere a composições sinérgicas de moléculas bioativas. mais particularmente, a invenção se refere a composições injetáveis contendo beta-glucanas e vitaminas, em diferentes concentrações, que quando administradas a animais levam a melhoria do balanço energético e do sistema imune, resultando em um aumento na produtividade de leite.pharmaceutical composition for milk producing animals. The present invention relates to synergistic compositions of bioactive molecules. More particularly, the invention relates to injectable compositions containing beta-glucans and vitamins, at different concentrations, which when administered to animals lead to improved energy balance and immune system, resulting in increased milk productivity.

BRPI1002298A 2009-06-23 2010-07-05 pharmaceutical composition for dairy animals BRPI1002298B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
BR2009000176 2009-06-23
ARP090103017 2009-08-06
ARP090103017A AR072925A1 (en) 2009-06-23 2009-08-06 PHARMACEUTICAL COMPOSITION FOR MILK PRODUCING ANIMALS, TO IMPROVE ENERGETIC BALANCE AND THE IMMUNE SYSTEM

Publications (3)

Publication Number Publication Date
BRPI1002298A2 BRPI1002298A2 (en) 2012-06-05
BRPI1002298A8 true BRPI1002298A8 (en) 2016-05-31
BRPI1002298B1 BRPI1002298B1 (en) 2019-01-15

Family

ID=41479601

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1002298A BRPI1002298B1 (en) 2009-06-23 2010-07-05 pharmaceutical composition for dairy animals

Country Status (2)

Country Link
AR (1) AR072925A1 (en)
BR (1) BRPI1002298B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021022045A1 (en) 2019-07-31 2021-02-04 Ecolab Usa Inc. Personal protective equipment free delimer compositions

Also Published As

Publication number Publication date
AR072925A1 (en) 2010-09-29
BRPI1002298B1 (en) 2019-01-15
BRPI1002298A2 (en) 2012-06-05

Similar Documents

Publication Publication Date Title
CL2015001389A1 (en) Compositions and anthelmintic compounds and methods for using them.
BR112013030894A2 (en) immune system modulators
BR112014019667A2 (en) abeta antibody formulation
GT201000182A (en) DOSAGE REGIME ASSOCIATED WITH INJECTABLE PALIPERIDONE ESTERS OF PROLONGED ACTION
BR112012016879A2 (en) Fatty acid fumarate derivatives and their uses
AR060247A1 (en) OLIGOSACARIDS OF MILK TO STIMULATE THE IMMUNE SYSTEM
AR097150A1 (en) FOOD FOR INFANT RUMENTS
BR112014016251A2 (en) compositions and methods for modification of gastrointestinal flora
BR112016008576A2 (en) STABLE AQUEOUS FORMULATIONS OF ANTIBODIES AND PHARMACEUTICAL UNIT DOSAGE FORM
BR112013004440A2 (en) method for parenteral administration of a composition, pharmaceutical composition for parenteral administration, kit and pharmaceutical system for parenteral administration
BR112015011430A2 (en) composition for immediate and prolonged release
AR097151A1 (en) FOOD FOR INFANT RUMENTS
MX2013003635A (en) N-heteroaryl compounds.
BRPI0822069B8 (en) method for preparing a milk thistle fruit extract
BR112013027474A2 (en) compositions that improve palatability
MX2009005965A (en) Animal feed compositions.
ECSP13012798A (en) METHOD FOR INHIBITING PATHOGENS USING A NUTRITIONAL COMPOSITION
BR112013028820A2 (en) medicinal food for cognitive decline
BR112014027301A2 (en) composition comprising a sensitive ingredient
AR100028A1 (en) NUTRITIONAL COMPOSITIONS CONTAINING ESTEARIDÓNIC ACID
BR112015029947A2 (en) nutrient release compositions and methods
BR112014013585A8 (en) methionine composition for animal nutrition
BRPI1002298A8 (en) pharmaceutical composition for dairy animals
CO6450623A2 (en) BLOOD PARASITICIDES
BR112015024323A2 (en) nutritional composition comprising whey and hydrolyzed casein and uses thereof

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B03H Publication of an application: rectification [chapter 3.8 patent gazette]

Free format text: REFERENTE A RPI 2161 DE 05/06/2012, QUANTO AOS ITENS (71) E (72).

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 05/07/2010, OBSERVADAS AS CONDICOES LEGAIS.